AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 221 filers reported holding AMICUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,978 | -22.3% | 985 | -19.7% | 0.00% | – |
| Q2 2023 | $15,411 | +523.2% | 1,227 | +450.2% | 0.00% | – |
| Q1 2023 | $2,473 | +38.7% | 223 | +52.7% | 0.00% | – |
| Q4 2022 | $1,783 | +78.3% | 146 | +80.2% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 81 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 81 | -1.2% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 82 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 82 | -64.8% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 233 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | -66.7% | 233 | -13.4% | 0.00% | – |
| Q4 2020 | $6,000 | +50.0% | 269 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | 0.0% | 269 | +15.5% | 0.00% | – |
| Q2 2020 | $4,000 | +100.0% | 233 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | +100.0% | 233 | +54.3% | 0.00% | – |
| Q4 2019 | $1,000 | – | 151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |